Literature DB >> 19285131

Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy.

Andrey M Mazarati1, Don Shin, Young Se Kwon, Anatol Bragin, Eduardo Pineda, Delia Tio, Anna N Taylor, Raman Sankar.   

Abstract

Depression is frequently reported in epilepsy patients; however, mechanisms of co-morbidity between epilepsy and depression are poorly understood. An important mechanism of depression is disinhibition within the hypothalamo-pituitary-adrenocortical (HPA) axis. We examined the functional state of the HPA axis in a rat model of co-morbidity between temporal lobe epilepsy and depression. Epilepsy was accompanied by the interictal elevation of plasma corticosterone, and by the positively combined dexamethasone/corticotropin releasing hormone test. The extent of the HPA hyperactivity was independent of recurrent seizures, but positively correlated with the severity of depressive behavior. We suggest that the observed hyperactivity of the HPA axis may underlie co-morbidity between epilepsy and depression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285131      PMCID: PMC2683188          DOI: 10.1016/j.nbd.2009.02.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  32 in total

1.  Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens.

Authors:  A Zangen; R Nakash; D H Overstreet; G Yadid
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

Review 2.  Which clinical and experimental data link temporal lobe epilepsy with depression?

Authors:  Daniel Kondziella; Silje Alvestad; Arne Vaaler; Ursula Sonnewald
Journal:  J Neurochem       Date:  2007-09-19       Impact factor: 5.372

Review 3.  The Flinders Sensitive Line rat: a selectively bred putative animal model of depression.

Authors:  David H Overstreet; Elliot Friedman; Aleksander A Mathé; Gal Yadid
Journal:  Neurosci Biobehav Rev       Date:  2005-04-22       Impact factor: 8.989

4.  Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor.

Authors:  Sarah A Johnson; Neil M Fournier; Lisa E Kalynchuk
Journal:  Behav Brain Res       Date:  2005-12-28       Impact factor: 3.332

5.  Epileptogenesis after self-sustaining status epilepticus.

Authors:  Andrey Mazarati; Anatol Bragin; Roger Baldwin; Don Shin; Charles Wilson; Raman Sankar; David Naylor; Jerome Engel; Claude G Wasterlain
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

6.  Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression.

Authors:  Melville M Leitch; Colin D Ingram; Allan H Young; Richard McQuade; Sarah E Gartside
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

7.  Rapid loss of dendritic spines after stress involves derangement of spine dynamics by corticotropin-releasing hormone.

Authors:  Yuncai Chen; Céline M Dubé; Courtney J Rice; Tallie Z Baram
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

8.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

Authors:  Andréy Mazarati; Prabha Siddarth; Roger A Baldwin; Don Shin; Rochelle Caplan; Raman Sankar
Journal:  Brain       Date:  2008-06-17       Impact factor: 13.501

10.  Endocrine abnormalities in human temporal lobe epilepsy.

Authors:  B B Gallagher
Journal:  Yale J Biol Med       Date:  1987 Mar-Apr
View more
  50 in total

1.  Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms.

Authors:  Eduardo Pineda; Don Shin; Raman Sankar; Andrey M Mazarati
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

Review 2.  Electrophysiological insights into the enduring effects of early life stress on the brain.

Authors:  Idrish Ali; Michael R Salzberg; Chris French; Nigel C Jones
Journal:  Psychopharmacology (Berl)       Date:  2010-12-17       Impact factor: 4.530

3.  Primed for Problems: Stress Confers Vulnerability to Epilepsy and Associated Comorbidities.

Authors:  Jamie Maguire
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

4.  Cognitive and behavioral comorbidities in epilepsy: the treacherous nature of animal models.

Authors:  Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Curr       Date:  2013-07       Impact factor: 7.500

Review 5.  Depression, stress, epilepsy and adult neurogenesis.

Authors:  Steve C Danzer
Journal:  Exp Neurol       Date:  2011-06-12       Impact factor: 5.330

6.  Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta.

Authors:  Andrey M Mazarati; Eduardo Pineda; Don Shin; Delia Tio; Anna N Taylor; Raman Sankar
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

Review 7.  Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy.

Authors:  Aynara C Wulsin; Matia B Solomon; Michael D Privitera; Steve C Danzer; James P Herman
Journal:  Physiol Behav       Date:  2016-05-16

Review 8.  Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?

Authors:  Andres M Kanner
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

Review 9.  Hippocampal granule cell pathology in epilepsy - a possible structural basis for comorbidities of epilepsy?

Authors:  Michael S Hester; Steve C Danzer
Journal:  Epilepsy Behav       Date:  2014-01-24       Impact factor: 2.937

10.  Early life stress as an influence on limbic epilepsy: an hypothesis whose time has come?

Authors:  Amelia S Koe; Nigel C Jones; Michael R Salzberg
Journal:  Front Behav Neurosci       Date:  2009-10-05       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.